Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Rheumatology (Oxford, England)|April 16, 2019
Polypharmacy is associated with treatment response and serious adverse events: results from the British Society for Rheumatology Biologics Register for Rheumatoid ArthritisKatie Bechman, Benjamin D Clarke, Andrew I Rutherford, et al.
Rheumatology (Oxford, England)|October 3, 2017
Optimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis-a proof of principle and exploratory trial: is dose tapering practical in good responders?Fowzia Ibrahim, Beatriz Lorente-Cánovas, Caroline J Doré, et al.
Rheumatology (Oxford, England)|August 3, 2010
Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderlyJames B Galloway, Kimme L Hyrich, Louise K Mercer, et al.
Annals of the Rheumatic Diseases|January 14, 2012
The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics RegisterLouise K Mercer, Adele C Green, James B Galloway, et al.
Rheumatology (Oxford, England)|January 16, 2023
COVID-19 admissions and mortality in patients with early inflammatory arthritis: results from a UK national cohortMaryam A Adas, Mark D Russell, Emma Cook, et al.
Rheumatology (Oxford, England)|May 5, 2025
Trends in remission rates for rheumatoid arthritis in England and Wales: a population-level cohort studyEdward Alveyn, Callum Coalwood, Grainne Farrell, et al.
Rheumatology (Oxford, England)|May 18, 2021
A systematic review and network meta-analysis of the safety of early interventional treatments in rheumatoid arthritisMaryam A Adas, Victoria B Allen, Mark Yates, et al.
Annals of the Rheumatic Diseases|August 10, 2016
Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid ArthritisLouise K Mercer, James B Galloway, Mark Lunt, et al.
Annals of the Rheumatic Diseases|April 26, 2012
Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics RegisterJames B Galloway, Louise K Mercer, Alison Moseley, et al.
The Journal of Rheumatology|March 16, 2022
Hospitalizations for Acute Gout: Process Mapping the Inpatient Journey and Identifying Predictors of AdmissionMark D Russell, Deepak Nagra, Benjamin D Clarke, et al.
Pageof 8